Health
health and longevity · the day's top 10 · june 12th
storyflo · health and longevity
Jun 12, 2026 · 2 min listen
Listen · storyflo · health and longevity
health and longevity · the day's top 10 · june 12th
0:00-1:59
Live · Kokoro-82M
Homemade Nutella is surprisingly easy to make with just raw hazelnuts and a little neutral oil. The spread, which is essentially a chocolate hazelnut paste, can replace the store‑bought version and works great on toast, fruit, crepes, waffles, or straight from the spoon.
Start with one cup of raw hazelnuts and two tablespoons of a neutral oil such as avocado or vegetable oil. Roast the nuts briefly to bring out flavor, then blend them in a food processor. The nuts will need a few minutes of blending to release their oils and become smooth; patience is key.
If the mixture feels too thick, drizzle in a bit more oil until it reaches a spreadable consistency. You don’t need to remove every bit of skin from the hazelnuts—getting most of it off is sufficient and won’t affect the final texture.
The result is about one cup of creamy, chocolate‑hazelnut spread that’s fresh, customizable, and free of added preservatives. Enjoy it as a versatile topping or snack, and feel the satisfaction of making it yourself.
Picture this! You’re HANGRY and you want something fast, fresh, and satisfying. Enter this fully loaded Mediterranean Bread Dipping Oil. In about 5 minutes, you are dragging a piece of charred, smoky sourdough through a shallow pool of olive oil loaded with fresh diced tomatoes, crisp cucumbers, briny green olives 🫒, and sharp red onion. It is bright, crunchy, and ridiculously good. This is not your typical Italian restaurant dipping oil. NO dried herb packets, NO boring oil on the side… This feels more like a Mediterranean garden in a bowl, built for scooping, dipping, and honestly eating straight off the platter. It is the perfect no-cook appetizer for summer mezze nights, or when you want something impressive with almost no effort. What makes it so good is the contrast. 😍 Smoky charred sourdough against cool, juicy vegetables and rich olive oil creates the perfect bite every time. And because it only takes 7 simple ingredients and 5 minutes, it is one of those recipes you end up making on repeat without thinking about it. Serve it fresh for the best texture, finish with a pinch of salt right before serving, and enjoy immediately while the bread is still warm and crisp! Enjoy! Macros + Interactive Checklist Nonna’s Tip Let the dip sit for 5–10 minutes before serving so the flavors can marry, then char the bread right before serving for the perfect smoky contrast. Subscribe now Leave a comment
The FDA has issued a recall for specific lots of Gas‑X Extra Strength gel capsules after testing revealed contamination with a coolant chemical that can irritate the gastrointestinal tract. The contaminant may trigger nausea, vomiting, stomach pain and diarrhea. The agency advises consumers to stop using the affected batches and to return them to pharmacies for a refund, while manufacturers work to replace the tainted product with safe stock.
A new epidemiological study links metabolic dysfunction‑associated steatohepatitis (MASLD) with an elevated risk of death from Alzheimer’s disease. Researchers analyzed health records of thousands of patients and found that those diagnosed with MASLD had a significantly higher mortality rate from Alzheimer’s compared with individuals without liver disease, even after adjusting for age, sex and cardiovascular risk factors. The findings suggest that metabolic liver disease may exacerbate neurodegenerative processes, underscoring the need for integrated screening and management of both liver health and cognitive decline.
A recent health‑services report highlights a stark geographic gap in gastroenterology care: many U.S. counties lack a single practicing gastroenterologist. Roughly one‑third of the nation’s counties, predominantly rural and low‑population areas, have no specialist on staff, forcing patients to travel long distances for diagnosis and treatment of digestive disorders. The shortage raises concerns about delayed care for conditions such as colorectal cancer, inflammatory bowel disease and liver disease, prompting calls for telemedicine expansion and incentives to attract specialists to underserved regions.
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Arghavan Salles, MD, PhD, explained how the "Streisand effect" led to skyrocketing engagement with the editorial...
Hi! Welcome to “good mood food” from Kale Me Maybe’s Carina Wolff. If you’ve made it here and aren’t yet a subscriber, come join! You can expect recipes, musings, and faves in your inbox every week! Paid subscribers get even more on Saturdays — right now I’m doing a 30-minute budget meal series! Learn more about the paid tier of my newsletter here. You can also try a week for free! Remember that song “All Day Long I Dream About Sex” from NSYNC member JC Chasez? (If you don’t, look it up, it’s a hilarious throwback.) I keep singing that song in my head but replacing “sex” with “food” because all day—and quite honestly, all night)—I’m thinking about food. Between my newsletter, Instagram videos, and cookbook recipes, my brain is just running through food combinations, constantly. So much so that I sometimes have a hard time falling back asleep at night because my mind is racing thinking about tomorrow’s meals. I probably need to work on that part. I finished Yesteryear, and I wasn't as disappointed by it as some people online, probably because I have followed the author on TikTok for awhile now and know where she’s coming from. However, I do feel like it fell a little short for me. I enjoyed the read, but my main critique was that I wish it had been a little more subtle in its messaging. As the reader, I felt a little too spoon-fed when it came to the author’s take on feminism, religion etc. That might just be a personal preference when it comes to the literature I like, but I do think all this discourse is proof that the author has provoked a lot of thought, which means she has accomplished something! Over the weekend, Grant, Sagan, Willow, and I took a walk in Griffith Park and got some pastries and tea at the Trails Cafe, and I was obsessed! I had low expectations for a kitschy little coffee shop at an extremely busy urban park, but both their drinks and food (which is all made in-house), were incredible! We got an iced almond palmer with lavender syrup, a cheddar and chive biscuit with butter, and a strawberry rhubarb crisp. I can’t wait to return in the cooler months—it’s such a vibe, and I can just imagine how nice it would be on a foggy fall morning! My brother got me these sourdough chocolate chip cookies for Mother’s Day, and I have been absolutely devouring them. It’s always nice to find packaged foods with good, simple ingredients, especially when they also happen to taste amazing. One day, I will learn to make my own, but until then, I’ll be snacking on these bad boys. I love a dainty, breezy white cotton top for summer, and this one from Madewell is a new favorite! I love the lace detailing, and it’s just the right amount of loose without being too billowy. Someone on Instagram asked me about sizing, and I would say it’s true to size (I got a medium). In addition to the white, there’s also a beautiful baby blue color. I am on a cherry kick right now, and it’s so much easier to cook and bake with them when you have a cherry pitter! This one is from Oxo, and it’s an absolute must if you want to enjoy an abundance of fresh cherries this season. I’ve been adding them to buckwheat porridge and cereal in the morning, and I just finished recipe testing a delicious cherry crumble for my cookbook! We are so back, baby! Meal Prep for Food Snobs has made its return, and this is one of my favorite ones so far. I’ll admit, as someone who doesn’t typically include ground turkey in many of my recipes, I started this one off a little skeptical, but by the end, I was stoked! The base of this week’s recipe is a hot honey za’atar ground turkey “sausage” that gets used in 3 recipes: a mediterranean bowl (classic me), a zucchini pasta (I think this one was my favorite, and a potato and kale frittata. I’m calling this a “sausage” because I imagined it as an alternative to a loose pork sausage, something seasoned like a breakfast sausage or Italian sausage. I polled you all on Instagram regarding the type of meat to use here, and the majority liked that it was ground turkey. However, you can always use ground chicken in its place or even pork, if that’s more of your thing. Ground turkey tends to dry out really easily, but the beauty of these recipes is that they’re mixed with a lot of other ingredients, so you don’t have to worry as much about the initial texture. However, here are my tips to avoid ground turkey that’s too dry: Use the highest percentage fat you can find, and add some fat into the recipe when cooking (I used butter in my recipe below) Avoid cooking the meat past 165°F.
Novartis announced that its RNA‑based therapy del‑brax successfully met the primary endpoints of a combined Phase 1/2 trial in patients with facioscapulohumeral muscular dystrophy (FSHD). The study, which evaluated safety, tolerability, and early efficacy signals, showed that participants tolerated the drug well and exhibited measurable improvements in muscle function and biomarker levels consistent with disease modulation.
FSHD is a hereditary muscle-wasting condition that affects the face, shoulder blades, and upper arms, and it currently has no FDA‑approved treatments. The trial’s results suggest that del‑brax could be the first disease‑modifying therapy for this patient population, offering a potential new standard of care for a disorder that has long lacked effective options.
Del‑brax is one of three RNA therapeutics that Novartis secured through its $12 billion acquisition of Avidity Biosciences. The deal gave the Swiss giant a pipeline of RNA‑based candidates aimed at rare diseases, positioning Novartis to expand its presence in the emerging field of RNA medicine.
Novartis plans to advance del‑brax into a larger pivotal trial later this year, seeking regulatory approval in the United States and Europe. If the upcoming study confirms the early benefits, the company could launch the first approved therapy for FSHD, marking a significant milestone for both patients and the broader RNA‑drug platform.
At the AHIP 2026 conference, senior executives from insurers, provider groups and health‑policy organizations gathered to discuss the Centers for Medicare & Medicaid Services’ latest Medicaid eligibility reforms. The new rules, slated to take effect later this year, tighten income‑verification standards, require more frequent recertifications and mandate the use of electronic data‑matching tools to confirm eligibility. CMS also plans to broaden coverage for certain low‑income populations, but the implementation timeline is compressed.
Industry leaders warned that the accelerated schedule could overwhelm state Medicaid agencies already stretched thin by budget constraints and staffing shortages. They highlighted the risk that tighter verification processes, if rolled out too quickly, might lead to unintended coverage gaps for vulnerable beneficiaries. Several speakers noted that the administrative costs of upgrading IT systems and training staff could divert resources from direct patient care.
In response, a coalition of health‑care leaders urged CMS to grant states a meaningful extension—suggesting a 12‑month delay or a phased rollout that would allow states to align their infrastructure and processes before the rules become mandatory. They argued that a collaborative approach would preserve continuity of care, reduce the likelihood of enrollment errors and give state agencies the breathing room needed to meet the new standards without sacrificing service quality.
The call for an extension reflects broader concerns about the balance between policy ambition and operational capacity. While CMS maintains that the reforms aim to improve program integrity and expand access, the industry consensus at AHIP stresses that realistic timelines and federal‑state coordination are essential to achieve those goals without disrupting
Novo Nordisk has reported a cybersecurity breach, becoming the latest biopharma company to fall victim to such an attack. The breach puts sensitive information at risk, including intellectual property and patient data. Biopharma companies have become prominent targets for cyber threats in recent years due to the valuable data they hold.
The breach is particularly concerning for clinical trial patients, who may have personal and medical information compromised. As a result, Novo Nordisk is advising these patients to remain vigilant and take steps to protect themselves. This may include monitoring their personal and financial information for any signs of unauthorized activity.
The breach is a reminder of the growing threat of cybersecurity attacks in the biopharma industry. Companies in this sector hold large amounts of sensitive data, making them attractive targets for hackers. The breach may also have implications for Novo Nordisk's business operations and reputation.
Novo Nordisk is likely to face scrutiny over its data protection measures and how it responds to the breach. The company will need to take steps to contain the breach, notify affected parties, and prevent similar incidents in the future. This may involve investing in new security measures and providing support to affected patients.
The incident highlights the need for biopharma companies to prioritize cybersecurity and take proactive steps to protect sensitive information. As the threat landscape continues to evolve, companies must stay vigilant and adapt their security measures to stay ahead of potential threats.
Genentech has announced another wave of job cuts, this time targeting senior leadership within its Research and Early Development division. Vice presidents Vishva Dixit, Man‑Wah Tan and Todd McDevitt were among those let go as the South San Francisco subsidiary of Roche reshapes its gRED organization.
The layoffs are part of a broader restructuring effort aimed at streamlining the research pipeline and reducing costs, though Roche has not disclosed the total number of positions affected. The move follows earlier rounds of reductions across the company, signaling an ongoing push to align staffing with evolving strategic priorities.
Industry observers note that the removal of three high‑profile VPs underscores the depth of the reorganization, suggesting a shift in focus for Genentech’s early‑stage development programs. While the exact impact on ongoing projects remains unclear, the cuts reflect a tightening of resources as the biotech giant adapts to a competitive market environment.
Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevitable revenue decline with a 200 billion yen ($1.3 billion) cost-savings program anchored in its new five-year strategic plan. But to CEO Naoki Okamura, “it’s not simply saving the cost or reducing the headcount.”
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.
We’ve simplified responses to 👍 / 👎. Past comments are archived but no longer visible.